INS and obesity disorder: The finding that trodusquemine determines an enhancement of insulin‐stimulated tyrosine phosphorylation of hypothalamic insulin receptor β in a mouse model of diet‐induced obesity proves that trodusquemine is able to cross the blood–brain barrier.10